Oragenics logo

Oragenics

OGENAMEX

Oragenics is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Janet Huffman, with a market cap of $2.7M.

Market Cap$2.7M
Employees5.0
CEOJanet Huffman
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
OGE

Oragenics FAQ

Common questions about Oragenics

Oragenics is scheduled to report earnings for Q1 2026 on May 8, 2026.

Oragenics has approximately 5 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.